Omega Diagnostics Group (ODX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 3.40p
   
  • Change Today:
      0.000p
  • 52 Week High: 10.73
  • 52 Week Low: 2.30
  • Currency: UK Pounds
  • Shares Issued: 327.69m
  • Volume: 183,921
  • Market Cap: £11.14m
  • Beta: 0.02

ODX Overview

Our mission is to improve human health and well-being through innovative diagnostic tests and global partnerships. Omega is focused on providing specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within Health & Wellbeing and Global Health.

1 Day Chart (06-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -10.9% -26.7%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.3 1.5
Pr/Book 0.9  
Latest F'cast
Revenue 25.2% -12.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ODX Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 13.55 (6.91) (0.37)p n/a n/a n/a n/a 0.0%
31-Mar-19 9.76 1.18 (0.09)p n/a n/a n/a n/a 0.0%
31-Mar-20 9.82 (8.30) (0.19)p n/a n/a n/a n/a 0.0%
31-Mar-21 6.82 (0.55) 0.38p 201.3 n/a n/a n/a 0.0%
31-Mar-22 8.54 (0.95) (0.40)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ODX Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-23 7.50 (2.00) (0.90)p n/a n/a n/a n/a 0.0%
31-Mar-24 11.00 (0.70) (0.30)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

ODX Company Announcements

Holding(s) in Company 27-Jan-2023 15:03 RNS
Director/PDMR Shareholding 27-Jan-2023 09:36 RNS
Trading update 18-Jan-2023 07:00 RNS

Latest ODX Director Deals

Traded Action Notifier PriceAmountValue
26-Jan-23 Buy Jag Grewal 3.48p 1,000,000 £34,839.00
26-Jan-23 Buy Christopher Paul Lea 3.48p 1,000,000 £34,839.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

ODX Market Data

Currency UK Pounds
Share Price 3.40p
Change Today 0.000p
% Change 0.00 %
52 Week High 10.73
52 Week Low 2.30
Volume 183,921
Shares Issued 327.69m
Market Cap £11.14m
Beta 0.02

ODX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.40% above the market average5.40% above the market average5.40% above the market average5.40% above the market average5.40% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average
Price Trend
56.31% below the market average56.31% below the market average56.31% below the market average56.31% below the market average56.31% below the market average
58.97% below the sector average58.97% below the sector average58.97% below the sector average58.97% below the sector average58.97% below the sector average
Income Not Available
Growth
22.52% below the market average22.52% below the market average22.52% below the market average22.52% below the market average22.52% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average

ODX Dividends

No dividends found

Trades for 06-Feb-2023

Time Volume / Share Price
15:15 2,309 @ 3.36p
14:52 3,250 @ 3.42p
14:31 14,890 @ 3.36p
12:05 10,000 @ 3.42p
11:43 10,817 @ 3.36p

ODX Key Personnel

CEO Jag Grewal
Chair Simon Gordon Douglas
CFO Christopher Paul Lea

Top of Page